Upon receiving good response for the first workshop on “Pitching your idea – Why and How?”, Biotechin.Asia is proud to present the second workshop of the Startup Workshop Series on “How To Pitch To a Biotech Investor?”.
This workshop will be held on June 24th 2016, 6 pm to 7.30 pm at NUS Enterprise@Blk71, Singapore (registration starts at 5:45 pm).
Workshop conducted by:
- Dr. Eddy Lee – Managing Partner, Coffee Ventures
The workshop will include:
- What goes onto the slide deck for pitching
- What you should/should not say to an investor who knows about the biotech and healthcare space
- Startup Case Study by Dr. Yann Chong Tan, Chief Technologist, Atreca, Inc.
- Networking Session (Light dinner will be provided)
About Eddy Lee:
Eddy Lee, PhD, Managing Partner | Coffee Ventures, Consulting Professor | Stanford University
Eddy Lee, PhD has invested in and supported more than 50 startups predominantly in the US, Singapore and Indonesia. Interest areas include mobile health, big data, IoT and marketplaces. He has recently relocated from the Silicon Valley to Southeast Asia to tackle unmet needs in emerging markets. He works with entrepreneurs in product development, enterprise partnership, M&A exit, and entering international markets such as the US, Japan, Singapore and Indonesia. At Stanford University, Eddy concurrently serves as a Consulting Professor at the School of Medicine, where he connects academic projects with commercial opportunities. He is also a mentor at Stanford’s StartX incubator where he provides startups with cross border knowhow.
About Yann Chong Tan:
Chief Technologist at Atreca, Inc.
Dr. Yann Chong Tan is a co-founder at Atreca. He led development of the technology underlying Atreca’s Immune Repertoire Capture™ platform while pursuing his dissertation research in William Robinson’s laboratory at Stanford University. He is the recipient of NSS(BS) and NSS(PhD) fellowships from the Agency for Science, Technology and Research (A*STAR) of Singapore. Dr. Tan received a BS in biology from Duke University and a PhD in immunology from Stanford University. In October 2015, the company Atreca, Inc announced the completion of its Series A funding with a total investment of $56 million.